×

img Acces sibility Controls

Research Projects Banner

Research Projects

Chondroinductive and chondroprotective small molecules decorated photocrosslinkable gel matrix systems for autologous chondrocyte Implantation (ACI) - a regenerative approach

Implementing Organization

Sree Chitra Tirunal Institute For Medical Sciences & Technology, Kerala
Principal Investigator
Dr. Lynda Velutheril Thomas
Sree Chitra Tirunal Institute For Medical Sciences & Technology, Kerala
CO-Principal Investigator
Dr. Neethu Mohan
Sree Chitra Tirunal Institute For Medical Sciences & Technology, Kerala
CO-Principal Investigator
Dr. sachin Jayachandran shenoy
Sree Chitra Tirunal Institute For Medical Sciences & Technology, Kerala

About

Autologous chondrocyte implantation is a common surgical intervention that requires expanded harvested chondrocytes from non-load bearing areas, leading to a loss of cell phenotype and poor biomechanical properties. Hydrogel systems have been found to be an effective encapsulating system for chondrocytes, maintaining cell viability and phenotype while supporting neocartilage formation. However, developing these gel structures into a 3D defect model is challenging. A two-component injectable hydrogel system based on chitosan, a'microfracture plus' surgical intervention, has been transferred to a start-up industry. This new hydrogel system offers a better regenerative approach for cartilage repair. The photocrosslinkable gel system, which can be injected with chondrocytes and photocrosslinked after application, offers a neutral pH environment for encapsulating chondrocytes. To maintain chondrogenic redifferentiation with hyaline-like phenotype and biofunctionality, small molecules like Kartogenin, salidroside, Kaempferol, and Honokiol can be conjugated into the gel system through controlled release strategies. The efficacy and biofunctionality of the different small molecule injectable gel systems will be assessed through autologous chondrocyte implantation using the proposed gel systems in a full thickness cartilage defect in a rabbit model. The results will enable clinical validation and attract industries to transfer this technology, leading to commercialization and supporting national efforts to boost the innovation ecosystem in the country.
Funding Organization
Funding Organization
Science and Engineering Research Board (SERB), New Delhi
Anusandhan National Research Foundation (ANRF)
Quick Information
Area of Research
Life Sciences & Biotechnology
Start Year
2023
End Year
2026
Sanction Amount
₹ 36.23 L
Status
Ongoing
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
N/A
Startup (If Any)
00
No. of Patents
Filed :00
Grant :00
arrowtop